Sera Prognostics Inc (NAS:SERA)

Q1 2025 Sera Prognostics Inc Earnings Call Transcript

May 7, 2025 / 09:00 PM GMT

Release Date Price: $2.4 (-4.76%)

Transcript 10-Q8-K

Key Points

Positve

Sera Prognostics Inc (SERA) reported net revenue of $38,000 for Q1 2025, marking an improvement from nil in Q1 2024.
The company is progressing towards the publication of its prime study results in a peer-reviewed journal, which could enhance its commercial momentum.
Sera Prognostics Inc (SERA) is focusing on Medicaid plan pilots in states with high premature birth rates, potentially leading to significant cost savings.
The company has a strategic plan to expand its sales force by 5 to 10 full-time employees to enhance its commercial presence.
Sera Prognostics Inc (SERA) has a strong cash position with approximately $114.2 million in cash equivalents and available-for-sale securities as of March 31, 2025.

Negative

Total operating expenses increased to $9.3 million in Q1 2025 from $9.1 million in the same period last year.
The company reported a net loss of $8.2 million for the quarter, relatively flat compared to $8.1 million in the previous year.
There is uncertainty regarding the timing of the publication of the prime study results, which could impact commercial progress.
Sera Prognostics Inc (SERA) faces challenges in building national awareness due to the high costs associated with broad media campaigns.
The company is shouldering the burden of building awareness for its preterm test, as it is the only molecular diagnostic test for predicting preterm birth on the market.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SERA.OQ - Sera Prognostics Inc
Q1 2025 Sera Prognostics Inc Earnings Call
May 07, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to the CER Prognostics conference call to review first quarter fiscal year 2025 results. At this time, all participants are in listen-only mode.

We will be facilitating a question and answer session toward the end of today's call.

As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter Denardo of Capcom Partners for a few introductory comments.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Andrew. Good afternoon, everyone. Welcome to Sara Prognostic's first quarter

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.